Global Biosimilar Monoclonal Antibody Market Research Report 2023

Report ID: 1983070 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Limited Dilution Method
        1.2.3 Micromanipulation
        1.2.4 Soft Agar Plate Method
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Biosimilar Monoclonal Antibody Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Chronic & Autoimmune Diseases
        1.3.3 Oncology
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biosimilar Monoclonal Antibody Market Perspective (2017-2028)
    2.2 Biosimilar Monoclonal Antibody Growth Trends by Region
        2.2.1 Biosimilar Monoclonal Antibody Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biosimilar Monoclonal Antibody Historic Market Size by Region (2017-2022)
        2.2.3 Biosimilar Monoclonal Antibody Forecasted Market Size by Region (2023-2028)
    2.3 Biosimilar Monoclonal Antibody Market Dynamics
        2.3.1 Biosimilar Monoclonal Antibody Industry Trends
        2.3.2 Biosimilar Monoclonal Antibody Market Drivers
        2.3.3 Biosimilar Monoclonal Antibody Market Challenges
        2.3.4 Biosimilar Monoclonal Antibody Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue
        3.1.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue (2017-2022)
        3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Players (2017-2022)
    3.2 Global Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biosimilar Monoclonal Antibody Revenue
    3.4 Global Biosimilar Monoclonal Antibody Market Concentration Ratio
        3.4.1 Global Biosimilar Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibody Revenue in 2021
    3.5 Biosimilar Monoclonal Antibody Key Players Head office and Area Served
    3.6 Key Players Biosimilar Monoclonal Antibody Product Solution and Service
    3.7 Date of Enter into Biosimilar Monoclonal Antibody Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Monoclonal Antibody Breakdown Data by Type
    4.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Type (2017-2022)
    4.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2023-2028)
5 Biosimilar Monoclonal Antibody Breakdown Data by Application
    5.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Application (2017-2022)
    5.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biosimilar Monoclonal Antibody Market Size (2017-2028)
    6.2 North America Biosimilar Monoclonal Antibody Market Size by Country (2017-2022)
    6.3 North America Biosimilar Monoclonal Antibody Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Biosimilar Monoclonal Antibody Market Size (2017-2028)
    7.2 Europe Biosimilar Monoclonal Antibody Market Size by Country (2017-2022)
    7.3 Europe Biosimilar Monoclonal Antibody Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biosimilar Monoclonal Antibody Market Size (2017-2028)
    8.2 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Country (2017-2022)
    8.3 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Biosimilar Monoclonal Antibody Market Size (2017-2028)
    9.2 Latin America Biosimilar Monoclonal Antibody Market Size by Country (2017-2022)
    9.3 Latin America Biosimilar Monoclonal Antibody Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biosimilar Monoclonal Antibody Market Size (2017-2028)
    10.2 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2017-2022)
    10.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Biocon
        11.1.1 Biocon Company Detail
        11.1.2 Biocon Business Overview
        11.1.3 Biocon Biosimilar Monoclonal Antibody Introduction
        11.1.4 Biocon Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.1.5 Biocon Recent Development
    11.2 Accord Healthcare
        11.2.1 Accord Healthcare Company Detail
        11.2.2 Accord Healthcare Business Overview
        11.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Introduction
        11.2.4 Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.2.5 Accord Healthcare Recent Development
    11.3 AET Biotech
        11.3.1 AET Biotech Company Detail
        11.3.2 AET Biotech Business Overview
        11.3.3 AET Biotech Biosimilar Monoclonal Antibody Introduction
        11.3.4 AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.3.5 AET Biotech Recent Development
    11.4 Amgen
        11.4.1 Amgen Company Detail
        11.4.2 Amgen Business Overview
        11.4.3 Amgen Biosimilar Monoclonal Antibody Introduction
        11.4.4 Amgen Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.4.5 Amgen Recent Development
    11.5 Celltrion
        11.5.1 Celltrion Company Detail
        11.5.2 Celltrion Business Overview
        11.5.3 Celltrion Biosimilar Monoclonal Antibody Introduction
        11.5.4 Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.5.5 Celltrion Recent Development
    11.6 Reddy's Laboratories
        11.6.1 Reddy's Laboratories Company Detail
        11.6.2 Reddy's Laboratories Business Overview
        11.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Introduction
        11.6.4 Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.6.5 Reddy's Laboratories Recent Development
    11.7 Hospira
        11.7.1 Hospira Company Detail
        11.7.2 Hospira Business Overview
        11.7.3 Hospira Biosimilar Monoclonal Antibody Introduction
        11.7.4 Hospira Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.7.5 Hospira Recent Development
    11.8 3SBio
        11.8.1 3SBio Company Detail
        11.8.2 3SBio Business Overview
        11.8.3 3SBio Biosimilar Monoclonal Antibody Introduction
        11.8.4 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.8.5 3SBio Recent Development
    11.9 Allergan
        11.9.1 Allergan Company Detail
        11.9.2 Allergan Business Overview
        11.9.3 Allergan Biosimilar Monoclonal Antibody Introduction
        11.9.4 Allergan Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.9.5 Allergan Recent Development
    11.10 Alvartis
        11.10.1 Alvartis Company Detail
        11.10.2 Alvartis Business Overview
        11.10.3 Alvartis Biosimilar Monoclonal Antibody Introduction
        11.10.4 Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2017-2022)
        11.10.5 Alvartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Limited Dilution Method
    Table 3. Key Players of Micromanipulation
    Table 4. Key Players of Soft Agar Plate Method
    Table 5. Key Players of Others
    Table 6. Global Biosimilar Monoclonal Antibody Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Biosimilar Monoclonal Antibody Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Biosimilar Monoclonal Antibody Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Biosimilar Monoclonal Antibody Market Share by Region (2017-2022)
    Table 10. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Biosimilar Monoclonal Antibody Market Share by Region (2023-2028)
    Table 12. Biosimilar Monoclonal Antibody Market Trends
    Table 13. Biosimilar Monoclonal Antibody Market Drivers
    Table 14. Biosimilar Monoclonal Antibody Market Challenges
    Table 15. Biosimilar Monoclonal Antibody Market Restraints
    Table 16. Global Biosimilar Monoclonal Antibody Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Biosimilar Monoclonal Antibody Market Share by Players (2017-2022)
    Table 18. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibody as of 2021)
    Table 19. Ranking of Global Top Biosimilar Monoclonal Antibody Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Biosimilar Monoclonal Antibody Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Biosimilar Monoclonal Antibody Product Solution and Service
    Table 23. Date of Enter into Biosimilar Monoclonal Antibody Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Biosimilar Monoclonal Antibody Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2017-2022)
    Table 27. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2023-2028)
    Table 29. Global Biosimilar Monoclonal Antibody Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2017-2022)
    Table 31. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2023-2028)
    Table 33. North America Biosimilar Monoclonal Antibody Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Biosimilar Monoclonal Antibody Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Biosimilar Monoclonal Antibody Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Biosimilar Monoclonal Antibody Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Biosimilar Monoclonal Antibody Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Biosimilar Monoclonal Antibody Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Biocon Company Detail
    Table 44. Biocon Business Overview
    Table 45. Biocon Biosimilar Monoclonal Antibody Product
    Table 46. Biocon Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 47. Biocon Recent Development
    Table 48. Accord Healthcare Company Detail
    Table 49. Accord Healthcare Business Overview
    Table 50. Accord Healthcare Biosimilar Monoclonal Antibody Product
    Table 51. Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 52. Accord Healthcare Recent Development
    Table 53. AET Biotech Company Detail
    Table 54. AET Biotech Business Overview
    Table 55. AET Biotech Biosimilar Monoclonal Antibody Product
    Table 56. AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 57. AET Biotech Recent Development
    Table 58. Amgen Company Detail
    Table 59. Amgen Business Overview
    Table 60. Amgen Biosimilar Monoclonal Antibody Product
    Table 61. Amgen Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 62. Amgen Recent Development
    Table 63. Celltrion Company Detail
    Table 64. Celltrion Business Overview
    Table 65. Celltrion Biosimilar Monoclonal Antibody Product
    Table 66. Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 67. Celltrion Recent Development
    Table 68. Reddy's Laboratories Company Detail
    Table 69. Reddy's Laboratories Business Overview
    Table 70. Reddy's Laboratories Biosimilar Monoclonal Antibody Product
    Table 71. Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 72. Reddy's Laboratories Recent Development
    Table 73. Hospira Company Detail
    Table 74. Hospira Business Overview
    Table 75. Hospira Biosimilar Monoclonal Antibody Product
    Table 76. Hospira Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 77. Hospira Recent Development
    Table 78. 3SBio Company Detail
    Table 79. 3SBio Business Overview
    Table 80. 3SBio Biosimilar Monoclonal Antibody Product
    Table 81. 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 82. 3SBio Recent Development
    Table 83. Allergan Company Detail
    Table 84. Allergan Business Overview
    Table 85. Allergan Biosimilar Monoclonal Antibody Product
    Table 86. Allergan Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 87. Allergan Recent Development
    Table 88. Alvartis Company Detail
    Table 89. Alvartis Business Overview
    Table 90. Alvartis Biosimilar Monoclonal Antibody Product
    Table 91. Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2017-2022) & (US$ Million)
    Table 92. Alvartis Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biosimilar Monoclonal Antibody Market Share by Type: 2021 VS 2028
    Figure 2. Limited Dilution Method Features
    Figure 3. Micromanipulation Features
    Figure 4. Soft Agar Plate Method Features
    Figure 5. Others Features
    Figure 6. Global Biosimilar Monoclonal Antibody Market Share by Application in 2021 & 2028
    Figure 7. Chronic & Autoimmune Diseases Case Studies
    Figure 8. Oncology Case Studies
    Figure 9. Others Case Studies
    Figure 10. Biosimilar Monoclonal Antibody Report Years Considered
    Figure 11. Global Biosimilar Monoclonal Antibody Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Biosimilar Monoclonal Antibody Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Biosimilar Monoclonal Antibody Market Share by Region: 2021 VS 2028
    Figure 14. Global Biosimilar Monoclonal Antibody Market Share by Players in 2021
    Figure 15. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibody as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Biosimilar Monoclonal Antibody Revenue in 2021
    Figure 17. North America Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Biosimilar Monoclonal Antibody Market Share by Country (2017-2028)
    Figure 19. United States Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Biosimilar Monoclonal Antibody Market Share by Country (2017-2028)
    Figure 23. Germany Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Biosimilar Monoclonal Antibody Market Share by Region (2017-2028)
    Figure 31. China Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Biosimilar Monoclonal Antibody Market Share by Country (2017-2028)
    Figure 39. Mexico Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Biosimilar Monoclonal Antibody Market Share by Country (2017-2028)
    Figure 43. Turkey Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Biosimilar Monoclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Biocon Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 46. Accord Healthcare Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 47. AET Biotech Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 48. Amgen Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 49. Celltrion Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 50. Reddy's Laboratories Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 51. Hospira Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 52. 3SBio Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 53. Allergan Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 54. Alvartis Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy's Laboratories
Hospira
3SBio
Allergan
Alvartis
Frequently Asked Questions
Biosimilar Monoclonal Antibody report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biosimilar Monoclonal Antibody report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biosimilar Monoclonal Antibody report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Biowaste Containers

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More